Literature DB >> 12052106

Genomics and proteomics may help clinicians individualize cancer treatment.

M J Friedrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12052106     DOI： 10.1001/jama.287.22.2931

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  1 in total

1.  Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia.

Authors:  Elena López Villar; Xiangdong Wang; Luis Madero; William C Cho
Journal:  J Cell Mol Med       Date:  2014-12-23       Impact factor: 5.310
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.